Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1799]
News [2697]
Articles [198]
Editorials [1]
Conferences [135]
elearning [13]
PDL1 and other biomarkers for selecting patients for immune checkpoint therapies
Dr Mary O'Brien - The Royal Marsden NHS Foundation Trust, London, UK
PDL1 and other biomarkers for selecting patients for immune checkpoint therapies ( Dr Mary O'Brien - The Royal Marsden NHS Foundation Trust, London, UK )
14 Sep 2016
Maintenance in NSCLC
Dr Benjamin Besse - Institut Gustave Roussy, Paris, France
Maintenance in NSCLC ( Dr Benjamin Besse - Institut Gustave Roussy, Paris, France )
14 Sep 2016
Editor's Choice for August 2016
Prof Gordon McVie - Editor in Chief, ecancer
Editor's Choice for August 2016 ( Prof Gordon McVie - Editor in Chief, ecancer )
22 Aug 2016
Breast cancer in the 21st century
Prof Debu Tripathy - MD Anderson Cancer Center, Texas, USA
Breast cancer in the 21st century ( Prof Debu Tripathy - MD Anderson Cancer Center, Texas, USA )
25 Jul 2016
Developments in gastrointestinal tumour treatment
Dr Ihor Pidhorecky - Memorial Cancer Institute, Hollywood, Florida, USA
Developments in gastrointestinal tumour treatment ( Dr Ihor Pidhorecky - Memorial Cancer Institute, Hollywood, Florida, USA )
25 Jul 2016
Editor's Choice for July 2016
Prof Gordon McVie - Editor in Chief, ecancer
Editor's Choice for July 2016 ( Prof Gordon McVie - Editor in Chief, ecancer )
25 Jul 2016
The steady progress of targeted therapies
Dr Anton Berns - Netherlands Cancer Institute, Amsterdam, Netherlands
The steady progress of targeted therapies ( Dr Anton Berns - Netherlands Cancer Institute, Amsterdam, Netherlands )
20 Jul 2016
Prof Michael Seckl: Why attend Future Horizons in Lung Cancer?
Prof Michael Seckl - Imperial College London, London
Prof Michael Seckl: Why attend Future Horizons in Lung Cancer? ( Prof Michael Seckl - Imperial College London, London )
17 Jul 2016
Polygenic risk and the targeted prevention of cancer
Prof Paul Pharoah - University of Cambridge, Cambridge, UK
Polygenic risk and the targeted prevention of cancer ( Prof Paul Pharoah - University of Cambridge, Cambridge, UK )
13 Jul 2016
Combination trial designs: efficient, effective and tolerable regimens
Dr Susan Galbraith – AstraZeneca, Macclesfield, UK
Combination trial designs: efficient, effective and tolerable regimens ( Dr Susan Galbraith – AstraZeneca, Macclesfield, UK )
4 Jul 2016
WIN 2016 highlights: Changing the understanding of cancer
Prof Richard Schilsky - Chief Medical Officer of the American Society of...
WIN 2016 highlights: Changing the understanding of cancer ( Prof Richard Schilsky - Chief Medical Officer of the American Society of Oncology (ASCO) )
1 Jul 2016
Results of the MINDACT clinical trial
Dr Suzette Delaloge - Institut Gustave Roussy, Paris, France
Results of the MINDACT clinical trial ( Dr Suzette Delaloge - Institut Gustave Roussy, Paris, France )
1 Jul 2016

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation